TPP Healthcare

The firm pursues control and significant minority investments in middle-market European healthcare companies, targeting pharmaceuticals, biotechnology, medical devices, and healthcare services. It focuses on established businesses with proven revenue models and avoids early-stage venture risk. Deal types include buyouts, growth equity, and corporate carve-outs from large pharmaceutical companies, per the firm's documented strategy.

TPP Healthcare primarily invests across Western Europe, with known deal activity in the United Kingdom, Germany, and the Nordic region. The firm's London headquarters positions it to source opportunities across both EU and non-EU markets, with a particular emphasis on countries with mature healthcare regulatory frameworks and reimbursement systems.

The firm raises capital from European institutional investors, including public and corporate pension funds, insurance companies, and single-family offices. These LPs are typically attracted to TPP Healthcare's pure-play healthcare mandate, which offers concentrated sector exposure without the diversification dilution found in generalist private equity funds.

TPP Healthcare typically leads its own deals and maintains control positions. It may selectively partner with other specialist healthcare investors on larger transactions where syndication is required, but unlike club-deal models, the firm does not rely on co-investor networks for deal sourcing — its pipeline is predominantly proprietary, built on founder and corporate relationships within the European healthcare sector.

The firm targets middle-market healthcare companies with EBITDA typically between €10 million and €50 million, deploying equity checks in the range of €20 million to €100 million per transaction. This positions TPP Healthcare above small-cap venture funds and below the large-cap buyout firms that dominate healthcare mega-deals.

The firm applies specialized operational expertise in healthcare regulation, reimbursement strategy, and clinical governance. It maintains a network of operating advisors, including former hospital executives and regulatory specialists, who work alongside portfolio company management to improve operational efficiency, expand service lines, and navigate complex European healthcare markets.

TPP Healthcare operates as an institutional asset manager raising capital from third-party European limited partners. It is not a single-family office, nor does it manage a permanent capital vehicle — the firm runs traditional closed-end private equity fund structures with a stated sector-exclusive healthcare mandate.